Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / weight management (FE-Compatible plans) | Covered with prior authorization |
| Obesity / weight management (standard commercial plans, non-formulary, exception required) | Not covered |
| Obstructive sleep apnea (SURMOUNT-OSA indication, FE-Compatible plans) | Covered with prior authorization |
If your plan denies coverage, two cash programs to check.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →
- Shed$199 a monthcompounded semaglutideCheck price →A health form first, then you choose your plan
Cheapest GLP-1 without insurance compares the three cash routes. Cheapest GLP-1 ranks every cash price on the chart.
Prior authorization: the plan reviews the prescription before it pays. Non-formulary: not on the plan's covered-drug list, so it takes an exception. FE-Compatible: one of the payer's plan groups. Its standard commercial series is the other.
Aetna covers Zepbound for weight loss on the plans it calls FE-Compatible. You need a BMI of 30, or 27 with a weight-related condition. Those plans also ask for six months in a structured weight-management program. On its standard commercial plans Zepbound is not on the drug list at all. Aetna dropped it from those lists on July 1, 2025. CVS Caremark, the company that runs Aetna's drug benefit, made that cut and named Wegovy the preferred weight-loss GLP-1. To get Zepbound on a standard plan you need a formulary exception, and you have to try Wegovy first. This answer covers commercial plans that are not Medicare.
Source: Aetna policy 6947-C, July 1, 2025. Checked June 18, 2026.
Where your plan lists it. Aetna's 2026 Advanced Control Plan drug guide lists Zepbound as a preferred brand, with prior authorization and a limit of 4 pens per 21 days. The Zepbound row also carries Aetna's SPC flag, so only select plans cover it. Your plan documents say whether yours is one. Source: 2026 Aetna Pharmacy Drug Guide, Advanced Control Plan, formulary updated September 1, 2026. Checked September 6, 2026.
What it costs once they say yes. With commercial insurance the manufacturer savings card takes Zepbound to as little as $25 a month. Your plan sets the copay before the card applies. What Zepbound costs with your plan.
This varies by plan. Self-funded employers build their own drug lists. One of them can keep Zepbound even though CVS Caremark dropped it from the standard list. So two people with the same Aetna card, at different companies, can get different answers. Check your summary of benefits, or call the number on your card.
Coverage by indication
| BMI threshold | BMI 30 or higher. BMI 27 or higher also qualifies with at least one weight-related condition: type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease |
| Step therapy | None. Policy 6947-C names no other drug you have to try first on FE-Compatible plans. |
| Continuation | At least 5 percent loss of baseline body weight within the first 3 months of therapy |
| Authorization length | 8 months initial, 12 months continuation |
What the prior authorization needs:
- FE-Compatible plan type is required; this policy does not apply to standard commercial plan series (ACCF, ACF, ACFC, SCCF, SF, SFC, VF, VFC)
- Documented BMI within the accepted threshold
- Six months of structured weight-management program participation (behavioral modification, reduced-calorie diet, increased physical activity)
- Comorbidity documentation if BMI is 27 to 29.9
Source: Aetna policy 6947-C, July 1, 2025. Official payer PA policy page (HTML).
Zepbound has been off the drug list for weight loss on the standard commercial plan series since July 1, 2025. Those series are ACCF, ACF, ACFC, SCCF, SF, SFC, VF and VFC. Policy 6981-A sets out the exception. You have to show you tried Wegovy first, which is semaglutide 2.4 mg by injection. If your prescriber says Wegovy is not safe for you, or you could not tolerate it, Aetna can grant the exception without that step. CVS Caremark took Zepbound off its Standard, Advanced Control and Value drug lists. An estimated 200,000 people were affected. The Massachusetts Office of Health and Human Services put the removal on the public record.
| Effective date | July 1, 2025 |
Source: Aetna policy 6981-A, July 1, 2025. Official payer PA policy page (HTML).
| BMI threshold | BMI 30 or higher |
| Sleep study (AHI) | Moderate to severe OSA, AHI 15 or more obstructive respiratory events per hour confirmed by polysomnography or home sleep apnea test |
| Authorization length | 6 months initial, 12 months continuation (requires documented positive treatment response with decreased OSA symptoms) |
What the prior authorization needs:
- FE-Compatible plan type required
- Established diagnosis of moderate to severe OSA with AHI 15 or higher
- BMI 30 or higher
- Concurrent reduced-calorie diet and increased physical activity
- Documented positive treatment response required for continuation
Source: Aetna policy 6947-C, July 1, 2025. Official payer PA policy page (HTML).
Recent change: CVS Caremark, which runs Aetna's drug benefit, took Zepbound off the standard drug lists on July 1, 2025. It said it had struck a price deal with Novo Nordisk, which makes Wegovy. Wegovy became the preferred weight-loss GLP-1 in its place. CVS Caremark says no other GLP-1 drug list changes are coming in 2026. Self-funded employer plans were not bound by the cut and can still cover Zepbound.
Ozempic, Mounjaro and Rybelsus on Aetna plans
Ozempic, Mounjaro and Rybelsus are approved for type 2 diabetes, not weight loss.
Does Aetna cover Ozempic?
Yes, with prior approval. Aetna pays for Ozempic once your prescriber gets the plan to sign off.
Aetna covers Ozempic for type 2 diabetes once the plan signs off. That sign-off runs under policy 2439-C from CVS Caremark, the company that runs Aetna's drug benefit. You need a documented type 2 diabetes diagnosis, for example an A1C of 6.5 percent or higher. You also need one more qualifying factor. Metformin that did not work, that you could not tolerate, or that is not safe for you is one. Combination therapy with an A1C of 7.5 percent or higher is another. Established cardiovascular disease and chronic kidney disease each qualify on their own. The quantity limit is one pen per fill for once-weekly dosing, and an approval lasts 12 months. Ozempic is not covered for weight loss. That use belongs to Wegovy, the same semaglutide at a higher dose.
Checked August 27, 2026.
What Aetna requires for Ozempic
| Step therapy | Metformin that did not work, that you could not tolerate, or that is not safe for you is one qualifying path. Combination therapy with an A1C of 7.5 percent or higher is another. Established cardiovascular disease and chronic kidney disease each qualify on their own. |
What the prior authorization needs:
- Documented type 2 diabetes diagnosis: A1C 6.5 percent or higher, fasting plasma glucose 126 mg/dL or higher, 2-hour OGTT plasma glucose 200 mg/dL or higher, or hyperglycemia symptoms with a random plasma glucose 200 mg/dL or higher (documentation required)
- For initial approval, patient has not already been on a stable GLP-1 or GIP/GLP-1 maintenance dose for at least 3 months
- One qualifying factor: inadequate response, intolerance, or contraindication to metformin; OR combination therapy with an A1C of 7.5 percent or higher; OR established cardiovascular disease; OR chronic kidney disease
- Quantity limit: one prefilled pen (3 mL) per 21 to 25 days for once-weekly dosing
- Prior authorization required; approval duration 12 months
Source: Aetna policy 2439-C. Official payer formulary / PA policy.
Does Aetna cover Mounjaro?
Yes, with prior approval. Aetna pays for Mounjaro once your prescriber gets the plan to sign off.
Aetna covers Mounjaro for type 2 diabetes once the plan signs off. Its pharmacy policy approves it if metformin did not work for you, if you cannot take metformin, or if you need combination therapy with an A1C of 7.5 percent or higher. Quantity limits apply. Aetna will not cover Mounjaro for weight loss, because the FDA approved it for type 2 diabetes only. The weight-loss version of the same drug, tirzepatide, is sold as Zepbound. That is a separate weight-loss benefit, and an employer has to choose to add it.
Checked August 27, 2026.
What Aetna requires for Mounjaro
| Step therapy | Required |
What the prior authorization needs:
- Diagnosis of type 2 diabetes. Mounjaro is not covered for type 1 diabetes.
- One of these: metformin did not work, you could not tolerate it, or it is not safe for you. Or you need combination therapy with an A1C of 7.5 percent or higher.
- Quantity limit of 4 single-dose pens or vials (2 mL) per 21 days, or 12 single-dose pens or vials (6 mL) per 63 days.
- Approval lasts up to 36 months. To keep it you need a stable maintenance dose for at least 3 months and a documented drop in A1C since you started.
Source: Aetna policy 5468-C. The plan's own prior-authorization policy.
Does Aetna cover Rybelsus?
Yes, with prior approval. Aetna pays for Rybelsus once your prescriber gets the plan to sign off.
Aetna covers Rybelsus for type 2 diabetes once the plan signs off, through CVS Caremark, the company that runs Aetna's drug benefit. You need a documented type 2 diabetes diagnosis. You also need one of these: metformin that did not work, that you could not tolerate, or that is not safe for you, or combination therapy with an A1C of 7.5% or greater. Rybelsus is not covered for weight loss. It has no weight-loss approval. The weight-loss semaglutide is Wegovy, and you take it as a shot.
Checked August 27, 2026.
What Aetna requires for Rybelsus
| Step therapy | Required |
What the prior authorization needs:
- Documented diagnosis of type 2 diabetes
- For new starts, the patient is not already on a stable maintenance dose of a GLP-1 agonist for at least 3 months
- Inadequate response, intolerance, or contraindication to metformin, or combination therapy with an A1C of 7.5% or greater
- Quantity limit: 30 tablets per 25 days, or 90 tablets per 75 days
- Continuation of therapy requires a demonstrated A1C reduction since starting a GLP-1 agonist
- Approval duration up to 36 months
Source: Aetna policy 3318-C. The plan's own prior-authorization policy.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read why plans say no and the four ways to appeal in the GLP-1 insurance guide.
- Your plan may treat another GLP-1 differently. The Aetna coverage check lists all 4, with the source for each.
- If the plan denies it, the appeal letter library has a template for each reason a plan gives. That covers the peer-to-peer call with a plan doctor, the Level 1 and Level 2 appeals inside the plan, and the outside review that follows them.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Aetna cover Zepbound?
Aetna covers Zepbound for weight loss on the plans it calls FE-Compatible. You need a BMI of 30, or 27 with a weight-related condition. Those plans also ask for six months in a structured weight-management program. On its standard commercial plans Zepbound is not on the drug list at all. Aetna dropped it from those lists on July 1, 2025. CVS Caremark, the company that runs Aetna's drug benefit, made that cut and named Wegovy the preferred weight-loss GLP-1. To get Zepbound on a standard plan you need a formulary exception, and you have to try Wegovy first. Policy checked June 2026.
What does Aetna require to approve Zepbound?
For obesity / weight management (FE-Compatible plans): The BMI requirement is BMI 30 or higher. BMI 27 or higher also qualifies with at least one weight-related condition: type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease. None. Policy 6947-C names no other drug you have to try first on FE-Compatible plans. Authorization runs 8 months initial, 12 months continuation.
Why might Aetna deny Zepbound even if I meet the criteria?
Self-funded employers build their own drug lists. One of them can keep Zepbound even though CVS Caremark dropped it from the standard list. So two people with the same Aetna card, at different companies, can get different answers. Check your summary of benefits, or call the number on your card.
Does Aetna cover Zepbound for sleep apnea?
Yes, with prior authorization. Aetna states this in Aetna Non-Medicare Prescription Drug Plan, Zepbound PA with Limit FE Compatible 6947-C P04-2025 (effective July 1, 2025), read June 2026.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Every page here comes from the payer's own policy, a federal law, or KFF's plan research. Each row links its source and gives the date we read it. Some plan files load at the address the payer gives but will not open. We check those against a second source and mark the row lower confidence. Job-based plans also choose whether to add the weight-drug benefit at all, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
